Short-term efficacy and toxicity of total neoadjuvant chemotherapy in patients with resectable gastric cancer
Background. Currently, perioperative chemotherapy is the standard treatment option for resectable gastric cancer (GC ) at stages higher than T1. Preoperative chemotherapy was shown do not adversely affect the course of the postoperative period in gastric cancer patients. However, approximately 60 %...
Saved in:
Main Authors: | A. V. Avgustinovich, S. G. Afanasyev, A. Yu. Dobrodeev, M. Yu. Volkov, D. N. Kostromitsky, L. V. Spirina, O. V. Cheremisina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2022-03-01
|
Series: | Сибирский онкологический журнал |
Subjects: | |
Online Access: | https://www.siboncoj.ru/jour/article/view/2023 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immediate results of neoadjuvant chemotherapy for resectable colon cancer
by: D. I. Azovsky, et al.
Published: (2025-03-01) -
Assessment of the safety and feasibility of neoadjuvant chemotherapy (2 cycles of FLOT chemotherapy + chemoradiotherapy) followed by surgery in the treatment of locally advanced gastric cancer
by: D. Yu. Mironova, et al.
Published: (2024-03-01) -
ANALYSIS OF HEMATOLOGIC, HEPATIC AND PANCREATIC TOXICITY DURING NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2018-07-01) -
Comparison of Neoadjuvant Chemotherapy With FLOT and Modified DCF Regimens in Nonmetastatic Gastric Adenocarcinoma
by: Mehdi Pourghasemian, et al.
Published: (2025-06-01) -
The ways to improve the results of the pylorus-preserving gastric resection
by: V. V. Grubnik, et al.
Published: (2021-10-01)